|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 20 of 33
Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | article | Shigesawa, Taku; Suda, Goki; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma | - | JGH open | - | Oct-2020 |
article | Kawagishi, Naoki; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Tokuchi, Yoshimasa; Kubo, Akinori; Kitagataya, Takashi; Shigesawa, Taku; Suzuki, Kazuharu; Ohara, Masatsugu; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Sakamoto, Naoya | Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C | - | Scientific reports | - | 28-Apr-2021 |
article | Shigesawa, Taku; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kubo, Akinori; Yamada, Ren; Furuya, Ken; Baba, Masaru; Kitagataya, Takashi; Suzuki, Kazuharu; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma | - | PLoS ONE | - | 1-Mar-2021 |
article | Yang, Zijian; Suda, Goki; Maehara, Osamu; Ohara, Masatsugu; Yoshida, Sonoe; Hosoda, Shunichi; Kimura, Megumi; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, Naoya | Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma | - | Cancers | - | 4-Jan-2022 |
article | Yang, Zijian; Suda, Goki; Maehara, Osamu; Ohara, Masatsugu; Yoda, Tomoka; Sasaki, Takashi; Kohya, Risako; Yoshida, Sonoe; Hosoda, Shunichi; Tokuchi, Yoshimasa; Kitagataya, Takashi; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, Naoya | Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma | - | Cancers | - | Feb-2023 |
article | Kubo, Akinori; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kitagataya, Takashi; Ohara, Masatsugu; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, Naoya | Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI | - | Cancers | - | Jul-2021 |
article (author version) | Sugiura, Ryo; Kuwatani, Masaki; Nishida, Mutsumi; Hirata, Koji; Sano, Itsuki; Kato, Shin; Kawakubo, Kazumichi; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | CORRELATION BETWEEN LIVER ELASTICITY BY ULTRASOUND ELASTOGRAPHY AND LIVER FUNCTIONAL RESERVE | - | Ultrasound in medicine and biology | - | Oct-2019 |
article | Kobayashi, Takahiko; Ishida, Junich; Shimizu, Yuichi; Kawakami, Hiroshi; Suda, Goki; Muranaka, Tetsuhito; Komatsu, Yoshito; Asaka, Masahiro; Sakamoto, Naoya | Decreased RNA-binding motif 5 expression is associated with tumor progression in gastric cancer | - | Tumor biology | - | 1-Mar-2017 |
article | Sho, Takuya; Suda, Goki; Ogawa, Koji; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Kobayashi, Tomoe; Meguro, Takashi; Saga, Akiyoshi; Miyagishima, Takuto; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Sakamoto, Naoya | Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting | - | JGH open | - | Feb-2020 |
article | Suzuki, Kazuharu; Suda, Goki; Yamamoto, Yoshiya; Abiko, Satoshi; Kinoshita, Kenji; Miyamoto, Shuichi; Sugiura, Ryo; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Kitagataya, Takashi; Shigesawa, Taku; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B | - | PLoS ONE | - | 20-Jan-2022 |
article | Sho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, Naoya | Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150 | - | Cancers | - | 15-Aug-2022 |
article (author version) | Suda, Goki; Kudo, Mineo; Nagasaka, Atsushi; Furuya, Ken; Yamamoto, Yoshiya; Kobayashi, Tomoe; Shinada, Keisuke; Tateyama, Miki; Konno, Jun; Tsukuda, Yoko; Yamasaki, Kazushi; Kimura, Megumi; Umemura, Machiko; Izumi, Takaaki; Tsunematsu, Seiji; Sato, Fumiyuki; Terashita, Katsumi; Nakai, Masato; Horimoto, Hiromasa; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C | - | Journal of gastroenterology | - | Jul-2016 |
article | Ohara, Masatsugu; Ohnishi, Shunsuke; Hosono, Hidetaka; Yamamoto, Koji; Yuyama, Kohei; Nakamura, Hideki; Fu, Qingjie; Maehara, Osamu; Suda, Goki; Sakamoto, Naoya | Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats | - | Stem cells international | - | 24-Dec-2018 |
article | Yoshida, Sonoe; Suda, Goki; Ohara, Masatsugu; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Kimura, Megumi; Akinori, Kubo; Tokuchi, Yoshimasa; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Maehara, Osamu; Ohnishi, Shunsuke; Sakamoto, Naoya | Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia | - | Nutrients | - | Jul-2021 |
article | Miyamoto, Shuichi; Suda, Goki; Ishikawa, Marin; Hayashi, Hideyuki; Nimura, Satoshi; Matsuno, Yoshihiro; Mori, Ryo; Tanishima, Shigeki; Kudo, Takahiko; Takagi, Tomofumi; Yamamoto, Yoshiya; Ono, Shoko; Shimizu, Yuichi; Sakamoto, Naoya | Genomic profiling of intestinal/mixed-type superficial non-ampullary duodenal epithelial tumors | - | JGH open | - | Sep-2021 |
article (author version) | Kawagishi, Naoki; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Shimazaki, Tomoe; Yamada, Ren; Kitagataya, Takashi; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Sakamoto, Naoya | High serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C | - | Hepatology Research | - | Jun-2020 |
article (author version) | Nakai, Masato; Ogawa, Koji; Takeda, Rei; Ohara, Masatsugu; Kawagishi, Naoki; Izumi, Takaaki; Umemura, Machiko; Ito, Jun; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Sakamoto, Naoya | Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis | Predictive factors of tolvaptan efficacy for LC | Hepatology Research | - | Feb-2018 |
article | Ohara, Masatsugu; Ogawa, Koji; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Shimazaki, Tomoe; Suzuki, Kazuharu; Nakamura, Akihisa; Umemura, Machiko; Izumi, Takaaki; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ohnishi, Shunsuke; Sakamoto, Naoya | L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis | - | Hepatology communications | - | Aug-2018 |
article | Kawagishi, Naoki; Suda, Goki; Nakamura, Akinobu; Kimura, Megumi; Maehara, Osamu; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Izumi, Takaaki; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Miyoshi, Hideaki; Sakamoto, Naoya | Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis | - | PLOS ONE | - | 2018 |
article | Hosoda, Shunichi; Suda, Goki; Sho, Takuya; Ogawa, Koji; Kimura, Megumi; Yang, Zijian; Yoshida, Sonoe; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Miyagishima, Takuto; Sakamoto, Naoya | Low baseline CXCL9 predicts early progressive disease in unresectable HCC with atezolizumab plus bevacizumab treatment | - | Liver Cancer | - | Jun-2023 |
Showing results 1 to 20 of 33
|